Other Clinical Trial - Colloidal Silver, Treatment of COVID-19

Status Recruiting

Clinical Trial Summary

Clinical Trial Description

Noble metals such as gold and silver have been appreciated for millennia not only for their beauty but also for their ability to fight diseases. Silver nanoparticles (AgNPs) have been employed as chemical drugs thanks to their unique physiochemical and chemical properties as well as biological features, such as anti-inflammatory, anti-angiogenesis, antiplatelet, antifungal, anti-cancer and antibacterial activities Infectious diseases account for more than 20% of global mortality and viruses are responsible for about one-third of these deaths. Highly infectious viral diseases such as severe acute respiratory (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease (COVID-19) are emerging more frequently and their worldwide spread poses a serious threat to human health and the global economy. The current COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . ;

Study Design

Related Conditions & MeSH terms

SARS (Severe Acute Respiratory Syndrome)
Severe Acute Respiratory Syndrome

Clinical Trial Details

NCT number	NCT04978025
Study type	Interventional
Source	Hôpital Universitaire Sahloul
Contact	Boukef Riadh, professor
Phone	00 216 98 676 745
Email	riadboukef@gmail.com
Status	Recruiting
Phase	N/A
Start date	November 1, 2020
Completion date	November 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04615052` - Home-based Exercise in COVID-19 Survivors	N/A
Completed	`NCT04720794` - A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion	N/A
Enrolling by invitation	`NCT04659486` - Adolescents With COVID-19/MIS-C at HCFMUSP	N/A
Completed	`NCT04784481` - Ivermectin Reproposing for Mild Stage COVID-19 Outpatients	Phase 1/Phase 2
Recruiting	`NCT04584658` - Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Active, not recruiting	`NCT04558476` - Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation	Phase 2
Withdrawn	`NCT04456426` - Characteristics of Patients With COVID-19 in Meta State, Colombia
Completed	`NCT04546581` - Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)	Phase 3
Completed	`NCT04446429` - Anti-Androgen Treatment for COVID-19	N/A
Completed	`NCT04701710` - Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan	Phase 1/Phase 2
Enrolling by invitation	`NCT05054075` - Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19	Phase 2
Withdrawn	`NCT04590274` - Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	Phase 1
Completed	`NCT04644159` - Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
Enrolling by invitation	`NCT04540185` - A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19	Phase 3
Recruiting	`NCT04497454` - Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)	N/A
Completed	`NCT04366908` - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome	Phase 2
Active, not recruiting	`NCT04390412` - Low Dose Radiotherapy in COVID-19 Pneumonia	Phase 1/Phase 2
Terminated	`NCT04382391` - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms	N/A
Recruiting	`NCT04560257` - High Flow Nasal Cannula HFNC In Covid-19 Patients	N/A
Recruiting	`NCT04559113` - Methylprednisolone in COVID-19 Patients (Methyl19LGH)	N/A